3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
5
Sarcoma
2
Radiation Injuries
2
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Radiation Pneumonitis
1
Radiation Fibrosis Syndrome
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma
1
Lymphedema
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Laryngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Flap Necrosis
1
Fibrosis
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Cisplatin
76
Radiotherapy
44
pembrolizumab
39
Cetuximab
38
Paclitaxel
34
Carboplatin
33
Docetaxel
30
Fluorouracil
25
Radiotherapy, Intensity-Modulated
22
Nivolumab
18
Drug Therapy
14
Radiation
12
Erlotinib Hydrochloride
9
cemiplimab
8
Magnetic Resonance Spectroscopy
8
130-nm albumin-bound paclitaxel
8
durvalumab
7
atezolizumab
7
Cyclophosphamide
7
Afatinib
7
Surgical Procedures, Operative
6
Panitumumab
6
Leucovorin
6
Chemoradiotherapy
6
fludarabine
5
aldesleukin
5
Radiosurgery
5
Oxaliplatin
5
Methotrexate
5
Gemcitabine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Squamous Cell
×
Hyperbaric Oxygenation
×
Clear all
NCT00474825
2012-02-06
HBO-XRT
National Baromedical Services
Phase 1
Completed
12 enrolled